puromycin aminonucleoside has been researched along with Body Weight in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (38.10) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagawa, Y; Kaneko, K; Kimata, T; Kino, J; Kitao, T; Tsuji, S; Yamanouchi, S | 1 |
| Chung, HC; Kwak, IS; Lee, DW; Lee, MY; Lee, SB; Seong, EY; Sol, MY; Song, SH; Yang, BY | 1 |
| Barrera, D; Correa-Rotter, R; Cruz, C; Hernández-Pando, R; Juárez-Nicolás, C; Medina-Campos, ON; Murguía, F; Pedraza-Chaverrí, J; Torres, N; Tovar, AR | 1 |
| Fogo, AB; Ma, J; Ma, LJ; Yang, HC | 1 |
| Fogo, AB; Ichikawa, I; Ma, J; Rossini, M; Yang, HC; Zuo, Y | 1 |
| Elema, JD; Grond, J; Weening, JJ | 1 |
| Kubota, K; Shimizu, F; Suzuki, KT; Yamada, YK; Yamamura, M | 1 |
| Bertram, JF; Ricardo, SD; Ryan, GB | 1 |
| Arévalo, AE; Pedraza-Chaverri, J | 1 |
| Bond, JS; Greenwald, R; Moak, S; Tang, J; Trachtman, H | 1 |
| Ascencio, C; Cruz, C; Pedraza-Chaverri, J; Sandoval, RL; Torres, N; Tovar, AR | 1 |
| Sabatino, B; Van Liew, JB | 1 |
| Azuma, H; Hamasaki, H; Ishizaka, K; Masuda, H; Matsubara, O; Sato, J; Tamaoki, S | 1 |
| Ascencio, C; Medina-Campos, ON; Pedraza-Chaverri, J; Torres, N; Tovar, AR | 1 |
| Freeman, RM; Rames, LK; Richards, CJ | 1 |
| Edwards, KD; Schapel, GJ | 1 |
| Karasawa, A; Kubo, K; Sano, J; Shirakura, S | 1 |
| Kaga, H; Kitou, N; Nagai, A; Nagasawa, M; Ooyama, S; Yoneda, T | 1 |
| Matsuda, H; Matsumoto, H; Miyahara, T; Nakano, H; Shibasaki, T | 1 |
| Fogo, A; Glick, AD; Homma, T; Ichikawa, I; Yoshida, Y | 1 |
| Bennett, B; Goldsmith, DI; Trachtman, H; Zavilowitz, B | 1 |
21 other study(ies) available for puromycin aminonucleoside and Body Weight
| Article | Year |
|---|---|
Antiproteinuric effect of an endothelin-1 receptor antagonist in puromycin aminonucleoside-induced nephrosis in rat.
Topics: Animals; B7-1 Antigen; Blood Pressure; Body Weight; Creatinine; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin-1; Female; Kidney; Kidney Diseases; Kidney Glomerulus; Nephrosis; Nephrotic Syndrome; NF-kappa B; Phenylpropionates; Podocytes; Proteinuria; Puromycin Aminonucleoside; Pyridazines; Rats; Rats, Wistar; Receptor, Endothelin A; Toll-Like Receptor 3 | 2018 |
Effects of celecoxib and nordihydroguaiaretic acid on puromycin aminonucleoside-induced nephrosis in the rat.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Weight; Celecoxib; Creatinine; Cyclooxygenase Inhibitors; Male; Masoprocol; Microscopy, Electron; Nephrosis; Podocytes; Puromycin Aminonucleoside; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors | 2009 |
Soy protein diet ameliorates renal nitrotyrosine formation and chronic nephropathy induced by puromycin aminonucleoside.
Topics: Animals; Antimetabolites; Antioxidants; Blood Urea Nitrogen; Body Weight; Catalase; Cholesterol; Creatinine; Diet; Eating; Glutathione Peroxidase; Glycine max; Immunohistochemistry; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Lipids; Male; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Soybean Proteins; Superoxide Dismutase; Tyrosine | 2004 |
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Antibiotics, Antineoplastic; Blood Pressure; Blood Proteins; Body Weight; Drug Evaluation, Preclinical; Glomerular Filtration Rate; Hypoglycemic Agents; Kidney; Male; Pioglitazone; Plasminogen Activator Inhibitor 1; Podocytes; PPAR gamma; Proliferating Cell Nuclear Antigen; Protective Agents; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sclerosis; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2006 |
Effects of podocyte injury on glomerular development.
Topics: Angiogenic Proteins; Animals; Animals, Newborn; Blood Pressure; Body Weight; Capillaries; Hypertension; Kidney Diseases; Kidney Glomerulus; Mice; Mice, Inbred ICR; Organ Size; Podocytes; Proteinuria; Puromycin Aminonucleoside; RNA, Messenger; Time Factors | 2007 |
Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
Topics: Animals; Blood Proteins; Body Weight; Carbon; Cholesterol; Doxorubicin; Glomerular Mesangium; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Histocytochemistry; Lipids; Male; Microscopy, Electron; Nephrosis; Platelet Count; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Triglycerides | 1984 |
A study on cadmium-induced nephropathy in rats pretreated with puromycin aminonucleoside.
Topics: Animals; Body Weight; Cadmium; Female; Kidney; Kidney Diseases; Organ Size; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1983 |
Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Body Weight; Diuresis; Female; Kidney Glomerulus; Microscopy, Electron; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thiourea; Vitamin E | 1994 |
Tissue lipoperoxidation and glutathione peroxidase activity in puromycin aminonucleoside injected rats.
Topics: Animals; Body Weight; Brain; Glutathione Peroxidase; Heart; Hypoproteinemia; Injections, Subcutaneous; Kidney; Lipid Peroxidation; Liver; Lung; Male; Myocardium; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Testis; Tissue Distribution | 1994 |
Meprin activity in rats with experimental renal disease.
Topics: Animals; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Doxycycline; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Metalloendopeptidases; Microvilli; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 1993 |
Reduced kidney branched chain aminotransferase expression in puromycin aminonucleoside-induced nephrotic syndrome.
Topics: Animals; Body Weight; Dietary Proteins; Eating; Kidney; Male; Nephrotic Syndrome; Puromycin Aminonucleoside; Rats; Rats, Wistar; RNA, Messenger; Transaminases | 1997 |
The renal handling of IgG in the aging rat and in experimental kidney disease.
Topics: Aging; Animals; Body Weight; Creatinine; Glomerulosclerosis, Focal Segmental; Immunoglobulin G; Kidney; Male; Potassium Dichromate; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Urine | 1997 |
Endogenous asymmetrical dimethylarginine and hypertension associated with puromycin nephrosis in the rat.
Topics: Animals; Arginine; Blood Pressure; Body Weight; Cyclic GMP; Endothelium; Glomerulosclerosis, Focal Segmental; Hypertension; Kidney; Male; Nitrous Oxide; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley | 1998 |
Hepatic histidase and muscle branched chain aminotransferase gene expression in experimental nephrosis.
Topics: Animals; Body Weight; Disease Models, Animal; Energy Intake; Gene Expression Regulation, Enzymologic; Histidine Ammonia-Lyase; Humans; Liver; Male; Muscle, Skeletal; Nephrotic Syndrome; Puromycin Aminonucleoside; Rats; Rats, Wistar; RNA, Messenger; Transaminases; Transcription, Genetic | 2000 |
Zinc metabolism in aminonucleoside-induced nephrosis.
Topics: Animals; Blood Proteins; Blood Urea Nitrogen; Body Weight; Bone and Bones; Hypercholesterolemia; Kidney; Male; Muscles; Nephrosis; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Serum Albumin; Testis; Zinc | 1975 |
Efficacy and interactions of oxandrolone, halo-fenate and clofibrate in a factorial study on experimental acute nephrotic hyperlipidemia.
Topics: Animals; Body Weight; Butyrates; Cholesterol; Clofibrate; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Female; Glycolates; Halofenate; Hyperlipidemias; Lipids; Liver; Nephrotic Syndrome; Organ Size; Oxandrolone; Puromycin Aminonucleoside; Rats; Statistics as Topic | 1975 |
Protective effect of benidipine against the development of glomerular sclerosis in experimental nephrotic syndrome.
Topics: Animals; Blood Pressure; Body Weight; Calcium Channel Blockers; Dihydropyridines; Glomerulosclerosis, Focal Segmental; Kidney; Male; Nephrotic Syndrome; Protamines; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Urine | 1992 |
[Nephrotoxicity test on T-3262 in rats with experimental nephropathy].
Topics: 4-Quinolones; Administration, Oral; Animals; Anti-Infective Agents; Body Weight; Fluoroquinolones; Kidney; Kidney Diseases; Male; Mercuric Chloride; Naphthyridines; Organ Size; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Urine | 1989 |
Effects of cyclosporine on puromycin aminonucleoside-induced nephrotic rats.
Topics: Animals; Body Weight; Cyclosporins; Kidney Glomerulus; Male; Nephrotic Syndrome; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1989 |
Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis.
Topics: Animals; Blood Pressure; Blood Urea Nitrogen; Body Weight; Chronic Disease; Disease Models, Animal; Doxorubicin; Glomerular Filtration Rate; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Kidney Glomerulus; Microsurgery; Proteinuria; Punctures; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1988 |
The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats.
Topics: Angiotensins; Animals; Body Weight; Captopril; Male; Nephrosis; Proline; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1985 |